O

Ophelia

Provides medication-assisted treatment for opioid dependence

Senior Analyst - Strategic Finance

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timeRemote in USA$125k - $130k

About the Job

Requirements

  • At least 3 years of experience in FP&A, accounting, or a comparable analytical finance role, with a track record of owning monthly close and reporting cycles.
  • A strong accounting foundation, including accrual concepts and how entries flow through the income statement, balance sheet, and cash flow statement.
  • Advanced Excel and financial modeling skills, including building models from scratch and auditing models created by others.
  • Experience in healthcare, ideally digital healthcare; multi-state operations; another regulated environment; or exposure to claims-based revenue.

Responsibilities

  • Own recurring components of the monthly close and work with the external accounting partner to maintain the close calendar.
  • Draft the monthly reporting package, covering total-company and state-level profit and loss statements, variable unit economics, and the leadership financials deck.
  • Build and maintain department- and state-level budget-versus-actual reporting; work with budget owners to explain variances and raise issues early enough to act.
  • Prepare external financial deliverables, including board and lender materials.
  • Support annual planning and reforecast cycles by partnering with department leads to collect and consolidate expense budgets.
  • Run ad hoc internal return-on-investment analyses with business partners to support company decision-making.

Desired Qualifications

  • Direct experience with NetSuite, Claude and Claude for Excel, or a business intelligence tool such as Lightdash.

About the Company

Ophelia

Provides medication-assisted treatment for opioid dependence

Ophelia delivers medication-assisted treatment (MAT) for opioid dependence through a direct-to-patient model that emphasizes privacy and convenience. Its core offering is medically guided treatment plans using approved MAT medications to reduce cravings and withdrawal, managed by a team of doctors, scientists, and tech professionals. Treatment is designed to be discreet and accessible, potentially bypassing traditional rehab settings in favor of private, patient-centered care. What sets Ophelia apart is its emphasis on privacy, convenience, and a modern approach that integrates medical expertise with technology to improve patient experience and outcomes. The company aims to normalize and expand access to MAT, reduce the stigma around rehab, and lower overdose risk by providing an effective, private alternative that helps people with opioid dependence make their own informed choices.

Company size
201-500
Company stage
Series B
Total funding
$67.8M
Headquarters
New York City, New York
Founded
2020

Recently Posted Jobs

Explore more opportunities at Ophelia

See more jobs